Modified mite allergen and pharmaceutical uses thereof

Details Modified mite allergen and pharmaceutical uses thereof Modified mite allergen and pharmaceutical uses thereof

2007-07-17

2010-02-02

Haddad, Maher M (Department: 1644)

Organic compounds -- part of the class 532-570 series

Organic compounds

Carbohydrates or derivatives

C536S023100

Reexamination Certificate

active

07655782

ABSTRACT:
The present invention provides a modifiedDermatophagoides pteronyssinusallergen Der p 5 protein which has ability to inhibit IgE binding when exposed against to the antigen. A method for treating allergy comprising administrating a therapeutically effective dose of the modifiedD. pteronyssinusallergen Der p 5 protein to a subject suffering from allergy Der p 5 is also provided.

REFERENCES:
patent: 6187311 (2001-02-01), Nishiyama et al.
Lin et al., “Allergens, IgE, mediators, inflammatory mechanisms—Characterization of Der p V allergen, cDNA analysis, and IgE-mediated reactivity to the recombinant protein”,J. Allergy Clin Immunol, Dec. 1994, pp. 989-996, vol. 94, No. 8, Part I.
van Hage-Hamsten et al., “Mechanisms of allergy—Skin test evaluation of genetically engineered hypoallergenic derivatives of the major birch pollen allergen, Bet v 1: Results obtained with a mix of two recombinant Bet v 1 fragments and recombinant Bet v 1 trimer in a Swedish population before the birch pollen season”,J. Allergy Clin Immunol, Nov. 1999, pp. 969-977, vol. 104, No. 5.
Beezhold et al., “Mutational analysis of the IgE epitopes in the latex allergen Hev b 5”,J. Allergy Clin Immunol, Jun. 2001, pp. 1069-1076, vol. 107, No. 6.
QuikChange Site-Directed Mutagenesis Kit. Instruction Manual. Catalog #200518 (30 reactions) and #200519 (10 reactions). Revision #0582008g.
Cell Proliferation ELISA, BrdU (colorimetric). Colorimetric immunoassay for the quantification of cell proliferation, based on the measurement of BrdU incorporation during DNA synthesis: A non-radioactive alternative to the [3H]-thymidine incorporation assay. Cat. No. 1647229, 1 kit [1000 tests]. Instruction Manual. Version 4, Dec. 2001.
Merriam-Webster OnLine Dictionary entry for prevent, downloaded Apr. 26, 2006, 2 pages.
Blumenthal et al., in Allergens and Immunotherapy, third edition, Marcel Dekker, Inc., 2004, pp. 37-50.
Burks et al., Eur J Biochem, 1997, 245:334-339.
Reese et al., J Immunol, 2005, 175:8354-8364.
Niu et al., Respiratory Medicine, Epub on Jan. 3, 2006, 10 pages.
QuikChange Site-Directed Mutagenesis Kit. Instruction Manual. Catalog #200518 (30 reactions) and #200519 (10 reactions). Revision #0582008g, 2002.

Affiliated with

Also associated with

Rating

Modified mite allergen and pharmaceutical uses thereof does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Modified mite allergen and pharmaceutical uses thereof, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Modified mite allergen and pharmaceutical uses thereof will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-4225564